GENMAB A/S - Common Stock

CUSIP: K3967W102

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / Common Stock
Shares outstanding
64,085,788
Total 13F shares
26,247
Share change
+22,962
Total reported value
$4,311,000
Price per share
$164.25
Number of holders
1
Value change
+$3,771,447
Number of buys
1

Sponsored

Quarterly Holders Quick Answers

What is CUSIP K3967W102?
CUSIP K3967W102 identifies K3967W102 - GENMAB A/S - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of K3967W102 - GENMAB A/S - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WILLIAMS JONES & ASSOCIATES LLC
13F
Company
0.01%
3,285
$420,000 31 Mar 2016
13F

Institutional Holders of GENMAB A/S - Common Stock as of Q2 2016

As of 30 Jun 2016, GENMAB A/S - Common Stock was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 26,247 shares. The largest 1 holders included Williams Jones & Associates LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders
1
Q2 2016 holders
1
Holder diff
0
Investor Q1 2016 Shares Q2 2016 Shares Share Diff Share Chg % Q1 2016 Value $ Q2 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.